1 Brotherton JML, Murray SL, Hall MA et al. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust 2013; 199: 614–617. 2 Brotherton JML, Liu B, Donovan B et al. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey. Vaccine 2014; 32: 592–597. 3 Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012; 30: F123–F138. 4 Day PM, Kines RC, Thompson CD et al. In vivo mechanisms of vaccine-induced protection against HPV infection. Cell Host Microbe 2010; 8: 260–270. 5 Joura EA, Garland SM, Paavonen J et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 2012; 344: e1401. 6 Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)? Gynecol Oncol 2013; 130: 257–261. 7 NHMRC. The Australian Immunisation Handbook 13th Edition 2013. Canberra: Australian Government. [Accessed 1 June 2014.] Available from URL: http://www.immunise.health. gov.au/internet/immunise/publishing.nsf/Content/Handbook 10-home. 8 Chief Medical Officer 2009. Guidance on Revaccination Where HPV Vaccine Doses Have Been Given at Less Than Recommended Minimum Intervals. [Accessed 1 June 2014.] Available from URL: http://www.health.gov.au/internet/ immunise/publishing.nsf/Content/cmo-full-advice-hpv-cnt. 9 Immunise Australia. HPV School Vaccination Program [Website]. [Accessed 1 June 2014.] Available from URL: http:// hpv.health.gov.au/ 10 Cancer Council Australia. HPV Vaccination [Website]. [Accessed 1 June 2014.] Available from URL: http://www. hpvvaccine.org.au/ 11 Macartney KK, Chiu C, Georgousakis M, Brotherton J. Safety of human papillomavirus vaccines: a review. Drug Saf 2013; 36: 393–412. 12 Arnheim-Dahlstr€ om L, Pasternak B, Svanstro ̈ m H et al. Autoimmune, neurological, and venous thromboembolic adverse events after vaccination of adolescent girls with quadrivalent human papillomavirus in Denmark and Sweden: cohort study. BMJ 2013; 347: 5906. Caution regarding first trimester screening for pre-eclampsia
[1]
J. Dodd,et al.
The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials
,
2014,
Journal of Human Hypertension.
[2]
S. Kane,et al.
New directions in the prediction of pre‐eclampsia
,
2014,
The Australian & New Zealand journal of obstetrics & gynaecology.
[3]
A. Brantsaeter,et al.
Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study.
,
2011,
American journal of epidemiology.
[4]
J. Strauss,et al.
Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medicalfood on pre-eclampsia in high risk population : Randomised controlled trial
,
2019
.
[5]
Kypros H Nicolaides,et al.
First-Trimester Prediction of Hypertensive Disorders in Pregnancy
,
2009,
Hypertension.
[6]
C. Homer,et al.
Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension
,
2008,
Journal of hypertension.